Semax

Semax is a synthetic neuropeptide with nootropic and neuroprotective effects, derived from an adrenocorticotropic hormone (ACTH) fragment.

SKU: 198885 Kategorija:
Aqsam l-imħabba tiegħek

The amino acid sequence of Semax is H-Met-Glu-His-Phe-Pro-Gly-Pro-OH. Carefully modified based on the fourth to seventh amino acids of a fragment derived from ormon adrenokortikotropiku (ACTH), this modification removes ACTH’s inherent side effects.

Preserving and in some cases enhancing neuroactive properties and stability, Semax demonstrates superior outcomes specifically related to neuroprotection and various forms of cognitive enhancement.

Enhancing learning and memory processes, konċentrazzjoni, and information processing speed are unique advantages the substance provides.

Direct influence on synaptic plasticity (hippocampal and cerebral cortex being prime examples) is what sets Semax apart; cognitive function is boosted by the body’s own physiological regulation, without addiction or fatigue.

Anxiety resistance and adaptogenic effects are also well documented, though immunomodulation is still being studied.

B'mod ġenerali, all the currently known neurotherapeutic effects of Semax hold great promise; Alzheimer’s, Parkinson’s, glaucoma, depression, and many other conditions of a neurological or psychiatric nature, will benefit from a truly effective cognitive enhancer.

Sekwenza

Ac-Met-Glu-His-Phe-Pro-Gly-Pro

Numru CAS

80714-61-0

Formula Molekulari

C39H54N10O10S

Piż Molekulari

854.99

Research Of Semax

1.Clinical Applications and Research Findings

Early approval was given in the 1990s for treating encephalopathy and stroke (circulatory related being the primary example), along with numerous neurological complications of non-insulin dependent diabetes.

Continuous research has since shown Semax to counteract a wide array of damaging brain stimuli – ischemia, hypoxia, tossiċità, and oxidative stress to name a few.

Potent antioxidant activity, improved intracellular energy metabolism within the brain, and enhanced survival of brain cells are all documented effects.

2.Effetti newroprotettivi

When the brain suffers damage from hypoxia, toxic substances, stress ossidattiv, or direct trauma, brain cells continuously die or lose function; irreversible injury follows as a result.

Semax has been demonstrated to inhibit or at least interrupt this process through various multi-target effects.

Experimental evidence shows upregulation of specific neurotrophic factors as one mechanism; activation of the TRKB receptor ġej, rapidly initiating neuronal differentiation and subsequent repair pathways – maximizing the potential for neuronal survival.

Suppressing the more acute toxicity of excitatory amino acids is another key action, as well as the inhibition of the initiation phase of cellular programmed apoptosis itself.

Clinical trials indicate effective reduction of infarct size and alleviation of cerebral edema in ischemic stroke patients; a solid foundation for all aspects of recovery (physical and psychological) is provided by Semax.

3.Titjib Konjittiv

Semax regulates the systemic balance of several neurotransmitters – dopamine, serotonin, aċetilkolina biex insemmu xi ftit – creating an efficient, stable environment within the nervous system.

Synaptic plasticity in critical regions (hippocampus being prime examples, prefrontal also important) is influenced by this regulation.

Physiologically regulating brain function leads to improved cognitive abilities; learning and memory (formazzjoni, consolidation and retrieval) are all enhanced, attention span increased, information processing speed improved and mental clarity restored.

Traditional stimulants cause the associated tension and anxiety that Semax completely avoids.

4.Anti-anxiety and Adaptogenic Effects

The hypothalamic-pituitary-adrenal (HPA) axis governs the body’s stress response.

Stabilizing this system is what Semax truly excels at – abnormal kortisol levels and all the pathological damage they cause from chronic stress are lessened.

5.Neuro-Repair and Neurotrophic Effects

Activating brain-derived neurotrophic factor (BDNF)/TrkB and other growth factor pathways, Semax provides a form of ‘revitalization’ to neurons, both structurally and functionally.

Axonal and network level reorganization can be achieved.

Surviving neurons can and do, in part at least, return to a near normal state of function.

Selank and Semax together are a powerful combination.

This combination represents a promising neuroprotective strategy.

COA

HPLC

MS

(1) Dmitrieva, V. G.; Povarova, O. V.; Skvortsova, V. I.; Limborska, S. A.; Myasoedov, N. F.; Dergunova, L. V. Semax u Pro-Gly-Pro Jattivaw it-Traskrizzjoni tan-Neurotrofini u l-Ġeni tar-Riċetturi tagħhom wara l-Iskemija Ċerebrali. Newrobijoloġija Ċellulari u Molekulari 2009, 30 (1), 71-79. DOI: 10.1007/s10571-009-9432-0.

(2) Eremin, K. O.; Kudrin, V. S.; Saransari, P.; Prodott, S. S.; Grivennikov, I. A.; Myasoedov, N. F.; Rayevsky, K. S. Semax, An ACTH(4-10) Analogu bi Nootropic Properties, Jattiva s-Sistemi tal-Moħħ Dopaminerġiċi u Serotoninerġiċi fl-annimali gerriema. Riċerka newrokimika 2005, 30 (12), 1493-1500. DOI: 10.1007/s11064-005-8826-8.

(3) Glazova, N. Y.; Manchenko, D. M.; Volodina, M. A.; Merchieva, S. A.; Andreeva, L. A.; Kudrin, V. S.; Myasoedov, N. F.; Levitskaya, N. G. Semax, ACTH sintetiku(4–10) analogu, jnaqqas l-alterazzjonijiet fl-imġieba u newrokimiċi wara espożizzjoni bikrija tal-fluvoxamine fil-firien bojod. Newropeptidi 2021, 86. DOI: 10.1016/j.npep.2020.102114.

(4) Spiża, N. V.; Sokolov, O.; Gabaeva, M. V.; Grivennikov, I. A.; Andreeva, L. A.; Miasoedov, N. F.; Zozulia, A. A. [Semax u selank jinibixxu l-enzimi li jiddegradaw l-enkephalin mis-serum uman]]. Bioorg Khim 2001, 27 (3), 180-183. DOI: 10.1023/a:1011373002885 Minn NLM Medline.

(5) Medvedeva, E. V.; Dmitrieva, V. G.; Limborska, S. A.; Myasoedov, N. F.; Dergunova, L. V. Semax, analogu ta 'ACTH(4−7), jirregola l-espressjoni ta 'ġeni ta' rispons immuni waqt ħsara iskemika fil-moħħ fil-firien. Ġenetika Molekulari u Ġenomika 2017, 292 (3), 635-653. DOI: 10.1007/s00438-017-1297-1.

(6) Pae, C.-U. Possibbiltà Terapewtika ta '"Semax" għad-Depressjoni. Spettri tas-CNS 2014, 13 (1), 20-21. DOI: 10.1017/s1092852900016102.

(7) Vlasova, I. M.; Buravtcov, D. E.; Saletsky, A. M. Analiżi tal-luminexxenza tal-komponenti tad-demm fi studji tal-proprjetajiet newroprotettivi tal-mediċina "Semax" fl-iskemija ċerebrali. Ġurnal ta 'Spettroskopija Applikata 2009, 76 (1), 121-126. DOI: 10.1007/s10812-009-9141-y.

Sekwenza:

Ac-Met-Glu-His-Phe-Pro-Gly-Pro

CAS:

80714-61-0

M.W:

823.928 g/mol

Dar Fittex Whatsapp Servizzi Prodott